Long-term outcomes of anatomic vs. non-anatomic resection in intrahepatic cholangiocarcinoma with hepatolithiasis: A multicenter retrospective study

Background The benefits of anatomic resection (AR) vs. non-anatomic resection (NAR) in patients with primary intrahepatic cholangiocarcinoma (ICC) with hepatolithiasis (HICC) are unclear. This study aimed to compare the long-term outcomes of AR vs. NAR in patients with HICC. Methods A total of 147 consecutive patients with HICC who underwent R0 hepatectomy were included. Overall survival (OS) and recurrence-free survival (RFS) following AR vs. NARs were compared using a 1:1 propensity score matching (PSM) analysis. A subgroup analysis was also conducted according to whether there are lymph node metastases (LNM). Results In a multivariate analysis, CA 19-9 (>39 U/L), microvascular invasion, LNM, and NAR were independent risk factors for poor RFS and OS rates, whereas multiple tumors were independent risk factors for OS. AR had better 1-, 3-, and 5-year RFS and OS rates than NAR (OS: 78.7, 58.9, and 28.5%, respectively, vs. 61.2, 25.4, and 8.8%, respectively; RFS: 59.5, 36.5, and 20.5%, respectively, vs. 38.2, 12.1, and 6.9%, respectively). After PSM, 100 patients were enrolled. The NAR group also had significantly poorer OS and RFS (OS: 0.016; RFS: p = 0.010) than the AR group. The subgroup analysis demonstrated that in HICC without LNM, OS and RFS were significantly poorer in the NAR group than the AR group, while no significant differences were observed in HICC with LNM before or after PSM. Conclusion Anatomic resection was associated with better long-term survival outcomes than NAR in patients with HICC, except for patients with LNM.

[1]  Jiamei Yang,et al.  Linoleic acid pathway disturbance contributing to potential cancerization of intrahepatic bile duct stones into intrahepatic cholangiocarcinoma , 2022, BMC Gastroenterology.

[2]  Shuqun Cheng,et al.  Long-Term Outcomes of Anatomic Versus Nonanatomic Resection in Hepatocellular Carcinoma Patients with Bile Duct Tumor Thrombus: A Propensity Score Matching Analysis , 2021, Annals of Surgical Oncology.

[3]  Yusuke Yamamoto,et al.  Anatomical resection is useful for the treatment of primary solitary hepatocellular carcinoma with predicted microscopic vessel invasion and/or intrahepatic metastasis , 2021, Surgery Today.

[4]  Zhengping Yu,et al.  The prognostic value of sarcopenia combined with hepatolithiasis in intrahepatic cholangiocarcinoma patients after surgery: A prospective cohort study. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[5]  Guangming Li,et al.  Anatomic versus non-anatomic resection for hepatocellular carcinoma, do we have an answer? A meta-analysis. , 2020, International journal of surgery.

[6]  G. Brandi,et al.  Asbestos and Intrahepatic Cholangiocarcinoma , 2020, Cells.

[7]  T. Pawlik,et al.  Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact Prognosis , 2020, Annals of surgery.

[8]  S. Chakraborty,et al.  Inflammation and Progression of Cholangiocarcinoma: Role of Angiogenic and Lymphangiogenic Mechanisms , 2019, Front. Med..

[9]  G. Torzilli,et al.  Surgical Treatment of Hepatocholangiocarcinoma: A Systematic Review , 2019, Liver Cancer.

[10]  T. Pawlik,et al.  Impact of Anatomical Versus Non-anatomical Liver Resection on Short- and Long-Term Outcomes for Patients with Intrahepatic Cholangiocarcinoma , 2019, Annals of Surgical Oncology.

[11]  Y. Chen,et al.  Nonanatomic resection is not inferior to anatomic resection for primary intrahepatic cholangiocarcinoma: A propensity score analysis , 2018, Scientific Reports.

[12]  Min Ji Kang,et al.  Incidence and Prognosis of Subsequent Cholangiocarcinoma in Patients with Hepatic Resection for Bile Duct Stones , 2018, Digestive Diseases and Sciences.

[13]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[14]  Elijah Dixon,et al.  Epidemiology and risk factors: intrahepatic cholangiocarcinoma. , 2017, Hepatobiliary surgery and nutrition.

[15]  Clinical Implications. , 2017, Hypertension.

[16]  W. Lau,et al.  Prognosis of Intrahepatic Cholangiocarcinomas with HBV Infection is Better than Those with Hepatolithiasis After R0 Liver Resection: A Propensity Score Matching Analysis , 2017, Annals of Surgical Oncology.

[17]  T. Pawlik,et al.  Monitoring outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection. , 2016, Hepatic oncology.

[18]  Han Zhang,et al.  Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management. , 2016, Cancer letters.

[19]  F. Thoemmes,et al.  Propensity Score Analysis , 2015 .

[20]  M. Okano,et al.  Cohort Study , 2020, Definitions.

[21]  T. Pawlik,et al.  Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. , 2014, Journal of hepatology.

[22]  T. Pawlik,et al.  Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis. , 2014, JAMA surgery.

[23]  Yao-Li Chen,et al.  Comparison of concomitant and subsequent cholangiocarcinomas associated with hepatolithiasis: Clinical implications. , 2013, World journal of gastroenterology.

[24]  N. Jarufe,et al.  Anatomic hepatectomy as a definitive treatment for hepatolithiasis: a cohort study. , 2012, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[25]  Y. Atomi,et al.  Predictive factors for cholangiocarcinoma associated with hepatolithiasis determined on the basis of Japanese Multicenter study , 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

[26]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[27]  Zhiyong Huang,et al.  Outcomes of non-anatomic liver resection for hepatocellular carcinoma in the patients with liver cirrhosis and analysis of prognostic factors , 2011, Langenbeck's Archives of Surgery.

[28]  Wei-Chen Lee,et al.  Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience. , 2010, Surgery.

[29]  Hong Wu,et al.  An Appraisal of Anatomical and Limited Hepatectomy for Regional Hepatolithiasis , 2010, HPB surgery : a world journal of hepatic, pancreatic and biliary surgery.

[30]  Wei Liu,et al.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case–control study in China , 2010, Liver international (Print).

[31]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[32]  H. Ojima,et al.  Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. , 2009, Surgery.

[33]  I. Endo,et al.  Anatomic versus limited nonanatomic resection for solitary hepatocellular carcinoma. , 2008, Surgery.

[34]  C. Su,et al.  Hepatolithiasis associated with cholangiocarcinoma , 1997, The British journal of surgery.

[35]  S. Fan,et al.  Intrahepatic Cholangiocarcinoma , 1997, World Journal of Surgery.